Skip to main content
Signal8

Federer Jessica

SEC insider (Form 3/4/5 filer). CIK 0001968187. Director at Sage Therapeutics, Inc. (SAGE). 2 reported Form 4/5 transactions since Sep 2024; latest on Jul 31, 2025. Located in CAMBRIDGE, MA.

Companies Federer Jessica has filed insider reports for

  • Sage Therapeutics, Inc. (SAGE): Director
Federer Jessica profile photo

Federer Jessica

CIK: 0001968187

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Sage Therapeutics, Inc. logo
SAGE

Sage Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Sage Therapeutics, Inc. logo
    SAGE

    Sage Therapeutics, Inc.

    Jul 31, 2025
    Disposition

    Stock Option (Right to Buy)

    Direct
    21.5K shares-
  • Sage Therapeutics, Inc. logo
    SAGE

    Sage Therapeutics, Inc.

    Jun 11, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    21.5K shares-

1-2 of 2